EXT2
protein-codingexostosin glycosyltransferase 2, the group of Exostosin glycosyltransferase family
Gene summary
This gene encodes one of two glycosyltransferases involved in the chain elongation step of heparan sulfate biosynthesis. Mutations in this gene cause the type II form of multiple exostoses. Alternatively spliced transcript variants encoding different isoforms have been noted for this gene. [provided by RefSeq, Jul 2008]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~156.3 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0014731
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AD
Disease ID:MONDO:0005508
Submitter: Orphanet
Inheritance Pattern: AD
Disease ID:MONDO:0007586
Submitter: Ambry Genetics
Inheritance Pattern: AR
Disease ID:MONDO:0014731
Submitter: Ambry Genetics
Inheritance Pattern: AD
Disease ID:MONDO:0007586
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AD
Disease ID:MONDO:0007586
Submitter: ClinGen
There is abundant evidence published associating the EXT2 gene with Hereditary Multiple Exostoses (HME) since the gene-disease relationship was first proposed by Stickens et al. (1996). Multiple case level studies have been performed with HME patients that have variants in the EXT2 gene. EXT1 also cause hereditary multiple exostoses and a working model for the formation of exostoses has been proposed to link the heparan sulfate biosynthesis function of EXT2. Multiple mouse and zebra fish models have been established to show the development of osteochondromas and exostoses with EXT2 deficiency. All of these types of evidence are consistent with a definitive relationship between the EXT2 gene and Hereditary Multiple Exostoses (HME).
Inheritance Pattern: AD
Disease ID:MONDO:0007586
Submitter: Genomics England PanelApp
Inheritance Pattern: AD
Disease ID:MONDO:0007586
Submitter: PanelApp Australia
Inheritance Pattern: AR
Disease ID:MONDO:0014731
Submitter: PanelApp Australia
Inheritance Pattern: AD
Disease ID:MONDO:0007586
Submitter: G2P
Inheritance Pattern: AR
Disease ID:MONDO:0014731
Submitter: Orphanet
Clinical Genomic Database (CGD)
Manifestation: Craniofacial; Gastrointestinal; Genitourinary; Musculoskeletal; Neurologic; Oncologic
Intervention: Oncologic
Rationale: Though data regarding the efficacy of surveillance are lacking, individuals are at risk for the (relatively infrequent) development of malignant change of exostoses, and awareness may allow early detection and management
Comments: Though onset of malignancy is typically described in adulthood, some individuals have been affected at an earlier age; Germline variants have also been implicated in chondrosarcoma
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to EXT2 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_207122.2. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 1 | 9 | 160 | 3 | 173 | |
| missense | 5 | 11 | 383 | 55 | 6 | 460 |
| nonsense | 53 | 20 | 2 | 75 | ||
| start loss | 0 | |||||
| frameshift | 90 | 21 | 2 | 113 | ||
| splice donor/acceptor (+/-2bp) | 34 | 12 | 7 | 53 | ||
| Total | 182 | 65 | 403 | 215 | 9 | 874 |
Highest pathogenic variant AF is 0.00005762289
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_997005.1 | 13 | MANE Select | |
| Ensembl | ENSP00000431173.2 | 13 | MANE Select | |
| RefSeq | NP_000392.3 | 14 | Standard | |
| RefSeq | NP_001171554.1 | 14 | Standard |
Model Organisms & Knockout Phenotypes
Observed phenotypic effects in mouse and zebrafish models
| Gene / Model | Organism | Observed Phenotype |
|---|---|---|
| ext2 | Danio rerio | Structure: retinal ganglion cell Quality: organization quality abnormal |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Glycosaminoglycan biosynthesis - heparan sulfate / heparin - Homo sapiens (human)
- Mesodermal Commitment Pathway
- Metabolism of carbohydrates
- HS-GAG biosynthesis
- Heparan sulfate/heparin (HS-GAG) metabolism
Biological Process
- ossification
- mesoderm formation
- glycosaminoglycan biosynthetic process
- protein glycosylation
- signal transduction
Molecular Function
- protein binding
- acetylglucosaminyltransferase activity
- glucuronosyltransferase activity
- transferase activity, transferring glycosyl groups
- heparan sulfate N-acetylglucosaminyltransferase activity
Cellular Component
- Golgi membrane
- endoplasmic reticulum
- endoplasmic reticulum membrane
- Golgi apparatus
- membrane
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000395673
- Coding exons
- 14
- Length
- 149881
- Individuals with no LoFs
- 125695
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 53
- Defined
- 125748
- p
- 0.000211
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 0.640 | 394 | 431 | 0.913 | 0.0000259 | 4918 |
| Missense (PolyPhen) | 129 | 160.21 | 0.80521 | 1844 | ||
| Synonymous | -0.242 | 169 | 165 | 1.02 | 0.00000981 | 1466 |
| Loss of Function | 2.73 | 21 | 39.5 | 0.532 | 0.00000216 | 444 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.00043 | 0.00043 | rare |
| Latino/Admixed American | 0.00026 | 0.00026 | rare |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0.00011 | 0.00011 | rare |
| Finnish | 0.000092 | 0.000092 | rare |
| European (Non-Finnish) | 0.00019 | 0.00019 | rare |
| South Asian | 0.00029 | 0.00026 | rare |
| Other | 0.00049 | 0.00049 | rare |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Glycosyltransferase required for the biosynthesis of heparan-sulfate. The EXT1/EXT2 complex possesses substantially higher glycosyltransferase activity than EXT1 or EXT2 alone. Appears to be a tumor suppressor. Required for the exosomal release of SDCBP, CD63 and syndecan (PubMed:22660413). {ECO:0000269|PubMed:22660413}.;
- Disease
- DISEASE: Potocki-Shaffer syndrome (POSHS) [MIM:601224]: A syndrome characterized by foramina parietalia permagna, multiple exostoses, and craniofacial dysostosis and mental retardation in some cases. Note=The gene represented in this entry is involved in disease pathogenesis.; DISEASE: Seizures, scoliosis, and macrocephaly syndrome (SSMS) [MIM:616682]: An autosomal recessive syndrome characterized by seizures, intellectual disability, hypotonia, scoliosis, macrocephaly, hypertelorism and renal dysfunction. {ECO:0000269|PubMed:26246518}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Recessive Scores
- pRec
- 0.121
Intolerance Scores
- LoFtool
- 0.0377
- RVIS EVS
- -0.48
- RVIS percentile EVS
- 22.75
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- E
- Indispensability score
- 0.748
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |